These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 28412963)

  • 1. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
    Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
    J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
    Knutson TP; Daniel AR; Fan D; Silverstein KA; Covington KR; Fuqua SA; Lange CA
    Breast Cancer Res; 2012 Jun; 14(3):R95. PubMed ID: 22697792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
    Daniel AR; Faivre EJ; Lange CA
    Mol Endocrinol; 2007 Dec; 21(12):2890-906. PubMed ID: 17717077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
    Daniel AR; Qiu M; Faivre EJ; Ostrander JH; Skildum A; Lange CA
    Steroids; 2007 Feb; 72(2):188-201. PubMed ID: 17173941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors.
    Qiu M; Olsen A; Faivre E; Horwitz KB; Lange CA
    Mol Endocrinol; 2003 Apr; 17(4):628-42. PubMed ID: 12554776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking progesterone receptor-mediated actions in breast cancer.
    Knutson TP; Lange CA
    Pharmacol Ther; 2014 Apr; 142(1):114-25. PubMed ID: 24291072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.
    Daniel AR; Lange CA
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14287-92. PubMed ID: 19706513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates.
    Truong TH; Dwyer AR; Diep CH; Hu H; Hagen KM; Lange CA
    Endocrinology; 2019 Feb; 160(2):430-446. PubMed ID: 30597041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
    Diep CH; Ahrendt H; Lange CA
    Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.
    Shen T; Horwitz KB; Lange CA
    Mol Cell Biol; 2001 Sep; 21(18):6122-31. PubMed ID: 11509655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
    Skildum A; Faivre E; Lange CA
    Mol Endocrinol; 2005 Feb; 19(2):327-39. PubMed ID: 15486045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.
    Hagan CR; Regan TM; Dressing GE; Lange CA
    Mol Cell Biol; 2011 Jun; 31(12):2439-52. PubMed ID: 21518957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer.
    Dwyer AR; Truong TH; Kerkvliet CP; Paul KV; Kabos P; Sartorius CA; Lange CA
    Br J Cancer; 2021 Jan; 124(1):217-227. PubMed ID: 33144693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 90 YEARS OF PROGESTERONE: Steroid receptors as MAPK signaling sensors in breast cancer: let the fates decide.
    Dwyer AR; Truong TH; Ostrander JH; Lange CA
    J Mol Endocrinol; 2020 Jul; 65(1):T35-T48. PubMed ID: 32209723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
    Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
    Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
    Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
    Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.
    Dressing GE; Knutson TP; Schiewer MJ; Daniel AR; Hagan CR; Diep CH; Knudsen KE; Lange CA
    Mol Endocrinol; 2014 Apr; 28(4):442-57. PubMed ID: 24606123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
    Faivre EJ; Daniel AR; Hillard CJ; Lange CA
    Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.
    Diep CH; Knutson TP; Lange CA
    Mol Cancer Res; 2016 Feb; 14(2):141-62. PubMed ID: 26577046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.
    Leehy KA; Regan Anderson TM; Daniel AR; Lange CA; Ostrander JH
    J Mol Endocrinol; 2016 Apr; 56(3):R99-R114. PubMed ID: 26831511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.